The initial field trials of DSM-5: new blooms and old thorns.
暂无分享,去创建一个
D. A. Lewis | D. Javitt | P. Shrout | J. Yager | D. Pine | C. Tamminga | M. Oquendo | E. Vieta | S. Schultz | R. Freedman | R. Michels | G. Gabbard | S. Gau
[1] S. Guze,et al. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. , 1970, The American journal of psychiatry.
[2] Emily A. Kuhl,et al. DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches. , 2013, The American journal of psychiatry.
[3] R. DeRubeis,et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. , 2010, JAMA.
[4] Helena C Kraemer,et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. , 2013, The American journal of psychiatry.
[5] A. Beck,et al. Personality disorders in DSM-5. , 2010, The American journal of psychiatry.
[6] Emily A. Kuhl,et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. , 2013, The American journal of psychiatry.
[7] Maurizio Fava,et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. , 2008, The American journal of psychiatry.